Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Hepatocellular × icaritin × Clear all

Phase

Phase 3 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Radiosurgery 17 lenvatinib 15 Radiofrequency Ablation 13 Hepatectomy 12 Sorafenib 10 Surgical Procedures, Operative 7 Magnetic Resonance Spectroscopy 7 camrelizumab 6 Radiotherapy 6 Immune Checkpoint Inhibitors 6 Blood Specimen Collection 6 apatinib 5 Electroporation 5 Bevacizumab 5 sintilimab 4 Yttrium-90 4 Proton Therapy 4 Oxaliplatin 4 Liver Transplantation 4 Doxorubicin 4 Catheter Ablation 4 tislelizumab 3 spartalizumab 3 atezolizumab 3 X-Rays 3 Standard of Care 3 Injections 3 Heavy Ion Radiotherapy 3 Fluorouracil 3 Embolization, Therapeutic 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06893887 2025-07-02

ICT-HCC

Nanjing Tianyinshan Hospital

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡